Clinical Trials Directory

Trials / Unknown

UnknownNCT03642405

Drug-induced Repolarization ECG Changes

Exploring the Effect of Methylphenidate and Antidepressants on Cardiac Repolarisation.

Status
Unknown
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
Copenhagen University Hospital at Herlev · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Studies have shown that the risk of developing heart arrhythmias, is increased in patients receiving medication for Attention-deficit hyperactivity disorder (ADHD) and depression. The QT-interval on a electrocardiogram (ECG) is often used to assess the patients risk of developing heart arrhythmias. The QT-interval defines the hearts electrical resting period and a long interval is linked to an increased risk of developing heart arrhythmias. In this project the investigators wish to examine possible side-effects in patients receiving medication for ADHD and depression and their dynamic QT-interval changes, by analysing the ECG changes that occur during "Brisk Standing".

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTElectrocardiogram examination12-lead ECG monitored by Holter
DIAGNOSTIC_TESTEchocardiographyEchocardiography in accordance to Danish Society of Cardiology
PROCEDUREBlood SamplesBlood Samples include, Genetic analysis, serum-Methylphenidate, serum-Citalopram. Sodium, Potassium, Magnesium, Calcium, Chloride, White-Blood-Count, Hemoglobin, C-reactive-Protein, Creatinine, Carbamide, aspartate aminotransferase (ASAT), alanine aminotransferase (ALAT), Glucose and pro-brain natriuretic peptide (Pro-BNP).
BEHAVIORALQuestionnaireQuestionnaire regarding patients quality of life

Timeline

Start date
2018-08-15
Primary completion
2019-09-03
Completion
2022-01-01
First posted
2018-08-22
Last updated
2019-01-03

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT03642405. Inclusion in this directory is not an endorsement.